27 February 2018 - Sobi announced today that the CADTH Canadian Drug Expert Committee has issued a conditional positive reimbursement ...
6 February 2018 - Maviret previously received a Notice of Compliance from Health Canada on 16 August 2017. ...
2 August 2017 - Positive recommendation moves Erelzi closer to federal, provincial and territorial drug plan reimbursement. ...
25 May 2017 - CADTH has published outcomes for edoxaban tosylate (Lixiana) and ivabradine hydrochloride (Lancora). ...
25 May 2017 - The CADTH Canadian Drug Expert Committee has recommended that emtricitabine/rilpivirine/tenofovir alafenamide be reimbursed as a complete ...
9 May 2017 - Gut-selective treatment now funded publicly for Canadians with ulcerative colitis and Crohn's disease. ...
18 April 2017 - Sarilumab was approved by Health Canada on 12 Jan 2017 for the treatment of adult patients ...
22 March 2017 - Recommendation states price needs to be reduced by 90%. ...
21 March 2017 - The cost of treatment with ustekinumab should not exceed the drug plan cost of the least costly ...
15 March 2017 - A report on new drugs for second-line therapy for 2 diabetes: a therapeutic review update is now ...
25 January 2017 - CADTH's first outcome for 2017 is in favour of the reimbursement of brivaracetam. ...
23 November 2016 - CADTH recommends use of levofloxacin inhalation solution. ...
26 October 2016 - CADTH publishes final recommendation on prevention of cardiovascular mortality in type 2 diabetes mellitus. ...
31 October 2016 - Takeda's Entyvio clocks up another CADTH recommendation. ...
25 October 2016 - The CADTH CDEC has recommend that ixekizumab be reimbursed for patients with moderate to severe plaque ...